Data show that compared with Caucasians, KRAS mutations in blood samples of Asians was more accurate and sensitive when using frozen tumor tissue samples and CTC methods compared to FFPE tissue samples and ctDNA. The gene discussed is KRAS; the disease is neoplasm.